On Thursday, June 15, 2017, at 12:30 PM EST, Goodwin will host a webinar discussing TC Heartland’s impact on where to bring Hatch-Waxman and biosimilars litigation.
The Supreme Court’s decision in TC Heartland, LLC v. Kraft Foods Group Brands LLC has reshaped venue in patent litigation, but the Court left unanswered several highly significant venue questions that regularly come up in Hatch-Waxman and biosimilars litigation.
- Where can a defendant that is an LLC, not a corporation, be sued?
- Where can a foreign defendant be sued?
- How will the alternative basis for venue (districts where a defendant “has committed acts of infringement” and has a “regular and established place of business”) work in Hatch-Waxman or biosimilars cases in which the acts of infringement are artificial? And what will happen when different ANDA filers simply cannot be sued in the same district?
To register for this webinar, click here.